ResearcherLMU KlinikumActive in the last 2 years
Lars M. König
Matched on ORCID iD 0000-0002-8348-7787; OpenAlex author ID A5101563990. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. Last author DOI 10.1136/jitc-2025-013282↗
- Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Last author DOI 10.1007/s00262-020-02605-9↗
- Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Co-author DOI 10.1186/s40425-019-0778-7↗
- Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Co-author DOI 10.1186/s40425-019-0830-7↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Max M. Schnurr · 4 shared papers, 2019–2026 · strength 0.52
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282↗
- Paper Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreat… DOI 10.1007/s00262-020-02605-9↗
- Paper Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. DOI 10.1186/s40425-019-0778-7↗
- Peter Duewell · 4 shared papers, 2019–2026 · strength 0.52
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282↗
- Paper Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreat… DOI 10.1007/s00262-020-02605-9↗
- Paper Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. DOI 10.1186/s40425-019-0778-7↗
- Sebastian Kobold · 3 shared papers, 2019–2026 · strength 0.42
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282↗
- Paper Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. DOI 10.1186/s40425-019-0778-7↗
- Paper Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreati… DOI 10.1186/s40425-019-0830-7↗
- Philipp Metzger · 3 shared papers, 2019–2020 · strength 0.27
- Paper Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreat… DOI 10.1007/s00262-020-02605-9↗
- Paper Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. DOI 10.1186/s40425-019-0778-7↗
- Paper Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreati… DOI 10.1186/s40425-019-0830-7↗
- Anne Marie Senz · 1 shared paper, 2026 · strength 0.26
- Steffen Ormanns · 1 shared paper, 2020 · strength 0.10
- Kirsten Lauber · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.